ZelosDx. - previously dba MSDx, Inc. - is structured around development of blood testing products that are designed to enable researchers to make breakthrough discoveries in brain health and disease. Principals of the firm are developing blood test(s) to predict which patients may develop neurodegenerative diseases like #Alzheimers. By coupling TMS research at the University of Arizona with biomarker tech from bioindustry, it is the judgment of management that a more holistic view could be achieved re. how the brain changes along the spectrum from healthy to cognitive decline.
